Cogent Biosciences Inc (COGT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

200 CAMBRIDGE PARK DRIVE CAMBRIDGE, MA 02140

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, PLX9486, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent Biosciences is headquartered in Cambridge, MA.

Data as of 2021-04-11 08:04:26 -0400
Market Cap308.34 Million Shares Outstanding37.194 Million Avg 30-day Volume317.232 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.22 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.60942 52-week High/Low14.44 / 0.34 Next Earnings Date2021-05-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for these stocks instead?

View SEC Filings from COGT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 4 25.0% 3 (0.18%) 3 (0.19%) 0.0%
Funds Holding: 68 36 88.89% 36 (2.16%) 18 (1.12%) 100.0%
13F shares: 32.621 Million 10.135 Million 221.85% 22.472 Million 8.514 Million 163.96%
% Ownership 89.3571 72.021 75.0602 -4.05%
New Positions: 41 17 141.18% 23 12 91.67%
Increased Positions 17 6 183.33% 7 3 133.33%
Closed Positions 8 6 33.33% 4 2 100.0%
Reduced Positions 9 7 28.57% 6 2 200.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding COGT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding COGT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FERRANTE KAREN JEAN

  • Director
2,121 2021-04-01 6

ROS MATTHEW

  • Director
2,068 2021-04-01 6

MORRIS ARLENE

  • Director
60,000 2021-03-11 2

HARWIN PETER EVAN

  • Director
60,000 2021-03-11 3

CAIN CHRISTOPHER W.

  • Director
60,000 2021-03-11 3

SHEGOG TODD

  • Director
22,500 2021-03-11 3

GREEN JOHN L. CHIEF FINANCIAL OFFICER

  • Officer
21,654 2021-02-25 5

SACHS JESSICA CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-10 2

ROBBINS ANDREW R PRESIDENT AND CEO

  • Officer
  • Director
0 2021-02-10 4

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP CO-INVESTMENT HOLDINGS III, LLC

VHCP MANAGEMENT II, LLC

VHCP MANAGEMENT III, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
4,355,273 2020-08-14 1

FAIRMOUNT FUNDS MANAGEMENT LLC

  • 10% Owner
6,235,903 2020-07-09 3

BOOTH BRUCE

  • Director
0 2020-07-01 2

ALDAG JORN

  • Director
0 2020-07-01 2

CAMPANA DARIO

  • 10% Owner
3,095,114 2020-04-06 0

HODGE GEOFFREY CHIEF TECHNICAL OFFICER

  • Officer
0 2020-02-11 0

ETTENBERG SETH CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-11 0

OSBORNE MATTHEW SCOTT CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-11 0

PEREZ ROBERT J

  • Director
0 2019-06-14 0

RATCLIFFE LIAM

  • Director
0 2019-06-14 0

WILSON CHARLES CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-03-01 0

VASCONCELLES MICHAEL CHIEF MEDICAL OFFICER

  • Officer
0 2019-03-01 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2018-04-03 0

FIL LTD

  • SEE REMARK 1
No longer subject to file 2018-04-03 0

ATLAS VENTURE FUND IX, L.P.

ATLAS VENTURE ASSOCIATES IX, L.P.

ATLAS VENTURE ASSOCIATES IX, LLC

  • 10% Owner
3,361,535 2018-04-03 0

STAMOULIS CHRISTIANA PRESIDENT & C.F.O.

  • Officer
0 2018-03-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FERRANTE KAREN JEAN - Director

2021-04-05 21:09:04 -0400 2021-04-01 A 2,121 $5.66 a 2,121 direct

ROS MATTHEW - Director

2021-04-05 21:06:49 -0400 2021-04-01 A 2,068 $5.66 a 2,068 direct

CAIN CHRISTOPHER W. - Director

2021-03-15 19:00:24 -0400 2021-03-11 A 60,000 a 60,000 direct

MORRIS ARLENE - Director

2021-03-15 18:54:53 -0400 2021-03-11 A 60,000 a 60,000 direct

HARWIN PETER EVAN - Director

2021-03-15 20:44:43 -0400 2021-03-11 A 60,000 a 60,000 direct

ROS MATTHEW - Director

2021-03-15 19:00:29 -0400 2021-03-11 A 60,000 a 60,000 direct

FERRANTE KAREN JEAN - Director

2021-03-15 19:05:56 -0400 2021-03-11 A 60,000 a 60,000 direct

SHEGOG TODD - Director

2021-03-15 19:00:39 -0400 2021-03-11 A 22,500 a 22,500 direct

GREEN JOHN L. - Officer CHIEF FINANCIAL OFFICER

2021-03-01 21:56:43 -0500 2021-02-25 A 524 a 21,654 direct -2.1635 -0.4808 0.0 1 -10.2163 3

SHEGOG TODD - Director

2021-02-24 18:36:09 -0500 2021-02-22 A 37,500 a 37,500 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
COGENT BIOSCIENCES INC COGT 2021-04-14 22:15:03 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 21:45:03 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 21:15:03 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 20:45:03 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 20:15:04 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 19:45:03 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 19:15:03 UTC -1.2533 1.3133 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 18:45:02 UTC -1.2537 1.3137 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 18:15:03 UTC -1.2537 1.3137 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 17:45:03 UTC -1.2537 1.3137 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 17:15:03 UTC -1.2537 1.3137 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 16:45:03 UTC -1.2479 1.3079 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 16:15:03 UTC -1.2479 1.3079 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 15:45:03 UTC -1.2479 1.3079 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 15:15:03 UTC -1.2479 1.3079 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 14:45:02 UTC -1.2407 1.3007 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 14:15:03 UTC -1.2407 1.3007 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 13:45:03 UTC -1.2407 1.3007 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 13:15:03 UTC -1.2407 1.3007 350000
COGENT BIOSCIENCES INC COGT 2021-04-14 12:45:03 UTC -1.2407 1.3007 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments